The question
Does the immune system stop some cancers from emerging or progressing?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Immune Surveillance Hypothesis
Does the immune system stop some cancers from emerging or progressing?
What you need to knowImmune control has strong support, but can hold cancer in check without removing every cancer cell.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone.
Review summary
Claim assessed: Innate and adaptive immune surveillance causally suppresses the emergence and progression of cancers by recognizing and controlling transformed cells.
Finding: Ζ for the preregistered SC1 scope-matched emergence-restraint gate, with Η established-tumour control and Γ elimination-dominance reported separately. The nominal claim says suppresses emergence/progression, not that all cancers require failed immunity or that suppression must sterilize cells. Weakest-link Γ is an explicit sensitivity to the additional elimination-exclusive subclaim, not a reason to demote the nominal restraint claim. The assembled set crosses Δ/Ε/Ζ through temporally and antigen-resolved native tests, orthogonal innate/adaptive mechanisms, human immune-status contrasts and randomized residual-outgrowth prevention; no single broad-deficiency leg is used as the sole instrument.
Key points
- SC1: Immune surveillance prevents or restrains emergence of clinical malignancy. — HSEF Ζ, Moderate confidence.
- SC2: Immune surveillance causally controls established tumours. — HSEF Η, Moderate confidence.
- SC3: Immune-mediated elimination rather than equilibrium or nonimmune dormancy explains latent-cell control. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Ζ — Multiple independent causal lines converge
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 65 primary reports; literature cutoff 2026-10-05; source examination UTC date 2026-10-06; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Immune control has strong support, but can hold cancer in check without removing every cancer cell.
Read the labels in this illustration
THE MAIN FINDING Immune control has strong support, but can hold cancer in check without removing every cancer cell. The idea What fits better What remains uncertain Does the immune system stop some cancers from emerging or progressing? Immune system acts Cancer cells removed Cancer stopped Proposed chain — plausible, not established Immune control can be a continuing standoff Best fit in this review Tumour held in check Surviving cells Later escape (proposed) How long the standoff can last What tips surviving cells toward escape Which tumours this describes Evidence comes from animals and cells — human tumours are harder to watch over time. Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone. Conceptual illustration
Best fit in this review
Immune control can be a continuing standoff
Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone.
Evidence for the stated claim
Strong, scope-limited evidence
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 2 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 2 among 5 compared models.
Leading explanation: Immune equilibrium and context-dependent editing.
Position in this comparison: Next after leading rank.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Does the immune system stop some cancers from emerging or progressing? Proposed chain Immunity Cells removed Cancer stopped Each arrow is a proposal, not a proven step. Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone. B · Leading explanation Immune control can be a continuing standoff Another explanation fits better Standoff: controlled, not cleared Later escape A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 2
Does the immune system stop some cancers from emerging or progressing?
Strong, scope-limited evidence for the stated claim.
Best fit in this review · rank 1
Immune control can be a continuing standoff
Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Immune equilibrium and context-dependent editing — Immune cells can suppress outgrowth while viable cells survive and escape.
Rank 2: Immune recognition and elimination — Transformed-cell recognition can remove susceptible cells and shape tumour emergence.
Rank 3: Cell-intrinsic stealth and quiescence — Latent cells reduce cycling and recognition to survive.
Rank 4: Niche and competition-mediated dormancy — Mechanical, stromal and cell-competition contexts restrain or promote residual cells.
Rank 5: Inflammatory or microbial promotion — Some immune or microbial states accelerate tumour growth or impair therapy.
What this means
?
Strong, scope-limited evidence
Immune control has strong support, but can hold cancer in check without removing every cancer cell.
Evidence rating: Ζ · Moderate confidence. How the evidence was assessed.
The important distinction
Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Immune control can be a continuing standoff. Viable tumour cells can survive under immune control and later escape. This explains more than complete removal alone.
What test tells them apart?
Track surviving tumour cells while changing immune control and checking later regrowth.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Track surviving tumour cells while changing immune control and checking later regrowth. then then Change the proposed cause Proposed test Measure the relevant outcome Proposed test Check the result independently Proposed test Immune control changed No change — control group Surviving tumour cells Later regrowth Tracked over time in each group. First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. Both groups are followed over time. Setting: animals This storyboard shows the logic of a test. It does not show a result. The question is whether control and escape can be watched as they happen. Conceptual illustration
A useful next question
Track surviving tumour cells while changing immune control and checking later regrowth.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: Prospectively trace antigen-defined premalignant clones in a prespecified high-risk human tissue and pair serial viable-cell/immune-contact measures with a narrowly targeted, ethically acceptable interception or rigorous natural immune-pathway contrast.
What would be measured: Clone survival, malignant conversion, immune engagement and subsequent clinical emergence
Important controls: Baseline antigen-negative clones, virus status, intrinsic growth traits and surveillance intensity; distinguish viable dormancy from absent detection
Result that would support the claim: Selective recognition engagement reduces conversion/outgrowth with a mediator-consistent contrast and independent replication
Result that would count against it: Engagement changes immune markers without clone fate or clinical emergence, or nonimmune traits fully explain the contrast
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →